SOAs

18/02/2020

Statement of Advice (SOA): chenodeoxycholic acid (Leadiant) 2862

18/02/2020

Statement of Advice (SOA): brexpiprazole (Rexulti) 1372

18/02/2020

Statement of Advice (SOA): botulinum toxin type A (Botox) 1845

18/02/2020

Statement of Advice (SOA): botulinum toxin type A (Botox) 2540

18/02/2020

Statement of Advice (SOA): bosutinib (Bosulif) 2507

21/02/2020

Statement of Advice (SOA): human coagulation factor X (Coagadex) 2910

21/02/2020

Statement of Advice (SOA): human normal immunoglobulin (Cuvitru) 3338

21/02/2020

Statement of Advice (SOA): human normal immunoglobulin (Octagam 5%) 3368

21/02/2020

Statement of Advice (SOA): human normal immunoglobulin (Panzyga) 3303

21/02/2020

Statement of Advice (SOA): human normal immunoglobulin (Octagam 10%) 3188

21/02/2020

Statement of Advice (SOA): human normal immunoglobulin (HyQvia) 1365

21/02/2020

Statement of Advice (SOA): human normal immunoglobulin (Privigen) 1979

21/02/2020

Statement of Advice (SOA): human normal immunoglobulin (Aragam) 1548

21/02/2020

Statement of Advice (SOA): human normal immunoglobulin (Kiovig) 1234

21/02/2020

Statement of Advice (SOA): human normal immunoglobulin (Hizentra) 3711

21/02/2020

Statement of Advice (SOA): hydrocortisone MR (Plenadren) 1039

21/02/2020

Statement of Advice (SOA): hydroxycarbamide (Siklos) 50

21/02/2020

Statement of Advice (SOA): ibritumomab tiuxetan (Zevalin) 159

21/02/2020

Statement of Advice (SOA): ibritumomab tiuxetan (Zevalin) 158

21/02/2020

Statement of Advice (SOA): ibrutinib (Imbruvica) 3279